The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

By Meg Flippin Benzinga

BioRestorative Therapies is a regenerative medicine company that wants to alleviate chronic lower back pain, obesity and diabetes and is developing stem cell therapies to meet that end. The company’s flagship program, BRTX-100, which is in a phase 2 clinical trial, uses a patient’s stem cells to alleviate chronic back pain. Meanwhile, ThermoStem®  uses adipose-derived (brown fat) stem cells to generate new brown fat tissue to target metabolic diseases, including obesity and type 2 diabetes. Both are addressing unmet health needs that inflict pain and suffering on millions of people around the world. 

Watch the full interview here: 
https://www.youtube.com/watch?v=JkHcW6QMRlg

Featured image by Joyce Hankins on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

This content was originally published on Benzinga. Read further disclosures here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.